John G. Stratton, Director at ABBOTT LABORATORIES (ABT), bought 4,297 shares at $72.32 ($311K) on 2019-01-31, disclosed to the SEC on 2019-02-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $72.31 | 100 | $7K | 2.3% |
| 2 | $72.31 | 613 | $44K | 14.3% |
| 3 | $72.32 | 100 | $7K | 2.3% |
| 4 | $72.32 | 842 | $61K | 19.6% |
| 5 | $72.32 | 842 | $61K | 19.6% |
| 6 | $72.33 | 1,800 |
| $130K |
| 41.9% |
| Total | $72.32 avg | 4,297 | $311K | 100% |
| Filing → |
| GD | BUY | 2020-03-05 | $1.0M | — | Filing → |